Impact of Insulin Resistance on Silent and Ongoing Myocardial Damage in Normal Subjects: The Takahata Study

Table 3

Comparisons of clinical characteristics in male and female subjects.

	Male	Female
Age (years)*	64.0 ± 10.2	62.7 ± 10.0^†
BMI (kg/m^2)*	22.9 ± 3.0	23.1 ± 3.5
sBP (mm Hg)*	136 ± 16	133 ± 16^†
dBP (mm Hg)*	82 ± 10	77 ± 9^†
BNP (pg/mL)**	17.6 (9.3–36.1)	21.4 (12.4–35.3)
TC (mg/dL)**	191 (173–211)	206 (187–226)^†
TG (mg/dL)**	95 (70–135)	89 (66–117)^†
HDLc (mg/dL)*	56 ± 14	61 ± 14^†
LDLc (mg/dL)*	119 ± 28	129 ± 28^†
eGFR (mL/min/1.73 m^2)**	82 (72–90)	106 (97–124)^†
H-FABP (ng/mL)**	3.7 (2.8–4.8)	3.4 (2.6–4.6)^†

BMI: body mass index; BNP: brain natriuretic peptide; TC: total cholesterol; TG: triglyceride; HDLc: high density lipoprotein cholesterol; LDLc: low density lipoprotein cholesterol; H-FABP: heart type fatty acid binding protein; sBP: systolic blood pressure; dBP: diastolic blood pressure; Data are presented as *mean ± S.D; **median (interquartile range); ^†P < 0.05 versus male.